These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16504672)

  • 1. Soluble HLA class I molecules exert differentiated influence on renal graft condition.
    Chudyk A; Masiuk M; Myślak M; Domański L; Sieńko J; Sulikowski T; Machaliński B; Giedrys-Kalemba S
    Transplant Proc; 2006; 38(1):90-3. PubMed ID: 16504672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
    Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
    Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia.
    Kippner L; Klint C; Sturfelt G; Bengtsson AA; Eriksson H; Truedsson L
    J Autoimmun; 2001 Jun; 16(4):471-8. PubMed ID: 11437496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of soluble HLA-G and its correlation with kidney transplant outcome.
    Kaneku H
    Clin Transpl; 2006; ():447-54. PubMed ID: 18365402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of soluble HLA class I molecules in children in bone marrow transplantation].
    Sedivá A; Starý J; Hromadníková I; Skalická A; Ghio M
    Cas Lek Cesk; 2000 Oct; 139(20):630-4. PubMed ID: 11192758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
    Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
    Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
    Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-beta1a treatment and their use as markers of disease activity.
    Minagar A; Adamashvilli I; Jaffe SL; Glabus MF; Gonzalez-Toledo E; Kelley RE
    Ann N Y Acad Sci; 2005 Jun; 1051():111-20. PubMed ID: 16126950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.
    Rizzo R; Campioni D; Stignani M; Melchiorri L; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Moretti S; Cuneo A; Lanza F; Baricordi OR
    Cytotherapy; 2008; 10(4):364-75. PubMed ID: 18574769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble HLA-G expression and renal graft acceptance.
    Qiu J; Terasaki PI; Miller J; Mizutani K; Cai J; Carosella ED
    Am J Transplant; 2006 Sep; 6(9):2152-6. PubMed ID: 16780545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
    House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
    Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation.
    Luque J; Torres MI; Aumente MD; Lozano JM; García-Jurado G; González R; Alvarez-López MR; Arizón JM; Peña J
    Transpl Immunol; 2006 Dec; 17(1):70-3. PubMed ID: 17157221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histocompatibility HLA system of man. Considerations in the light of current concepts. V. sHLA-I in patient's body fluids].
    Kedzierska A; Turowski G
    Przegl Lek; 2001; 58(9):868-72. PubMed ID: 11868250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA class I antigen matching and early graft outcome in living donor kidney transplantation.
    Iqbal MM; Hossain RM; Rashid HU; Rahman MH; Datta M; Hassan MS
    Transplant Proc; 2006 Sep; 38(7):2012-3. PubMed ID: 16979982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of blood transfusions: the synergic role of soluble HLA Class I free heavy-chain molecules detectable in blood components.
    Ghio M; Contini P; Ubezio G; Mazzei C; Puppo F; Indiveri F
    Transfusion; 2008 Aug; 48(8):1591-7. PubMed ID: 18466172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.
    Sebti Y; Le Maux A; Gros F; De Guibert S; Pangault C; Rouas-Freiss N; Bernard M; Amiot L
    Br J Haematol; 2007 Jul; 138(2):202-12. PubMed ID: 17593027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.